Skip to main content
Erschienen in: The Journal of Headache and Pain 1/2015

Open Access 01.12.2015 | Oral presentation

O038. I.V. methylprednisolone plus diazepam in medication-overuse headache

verfasst von: Matteo Paolucci, Riccardo Altavilla, Giulia Gambale, Claudia Altamura, Fabrizio Vernieri

Erschienen in: The Journal of Headache and Pain | Sonderheft 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Medication-overuse headache (MOH) is a secondary chronic headache developing as a consequence of prolonged overuse of symptomatic headache drugs for at least 3 consecutive months. It usually, but not invariably, resolves after the overuse is discontinued[1]. Benefit of acute withdrawal of the overused medication has been shown to be effective[2]; performing a transitional therapy (“bridge therapy”) during the days of withdrawal may ensure symptomatic relief from rebound headache and avoid withdrawal symptoms. In this setting, i.v. methylprednisolone may have a protective role[3].
This retrospective study aimed to evaluate the effectiveness of detoxification protocol applied in our Headache Centre, which consists in interruption of the abused drug and in the intravenous administration of methylprednisolone 125 mg plus diazepam 10 mg and esomeprazole 40 mg for 5 consecutive days. Depending on patients’ features, prophylactic therapy for chronic headache was either introduced or modified by the end of the wash-out. We enrolled 36 patients with MOH who underwent wash-out between 2010 and 2014, for whom follow-up data were available. Then we compared these patients with a control group of 21 MOH patients who did not undergo detoxification protocol, but only changed prophylactic therapy. Considered end points were mean monthly days of headache and the percentage of response to treatment at one (T1) and three months (T3): patients were divided into “responders” and “high responders” if reduction was > 50%.
At T0, mean monthly days of headache was 25 in the washout group and 20 in the control group; at T1 means decreased to 8 in the washout group and 11 in the control group (Mann-Whitney U test, p 0.012), with a 68% reduction in the washout group and 40% reduction in the control group. At T3 means were 10 for both groups (p 0.103), with a reduction from baseline of 60% in the washout group and 50% in the control group. At T1 we found 54.4% of “responders” in the washout group, versus 22.8% of responders in the control group (Fisher's exact test, p 0.04); “high responders” rates were 40.4% in the washout group versus 8.8% in the control group (p 0.004). At T3 differences in “responders” and “high responders” rate between the two groups were attenuated, losing statistical significance.
This retrospective study shows that a detoxification protocol with i.v. methylprednisolone and diazepam is widely effective and ensures an adequate reduction of headaches.
Written informed consent to publication was obtained from the patient(s).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://​creativecommons.​org/​licenses/​by/​4.​0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Headache Classification Committee of the International Headache Society (IHS): The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013, 33: 629-CrossRef Headache Classification Committee of the International Headache Society (IHS): The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013, 33: 629-CrossRef
2.
Zurück zum Zitat Zeeberg P, Olesen J, Jensen R: Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006, 26: 1192-10.1111/j.1468-2982.2006.01190.x.CrossRefPubMed Zeeberg P, Olesen J, Jensen R: Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006, 26: 1192-10.1111/j.1468-2982.2006.01190.x.CrossRefPubMed
3.
Zurück zum Zitat Cevoli S, Giannini G, Favoni V, Sancisi E, Nicodemo M, Zanignini S, Grimaldi D, Pierangeli G, Cortelli P: Treatment of withdrawal headache in patients with medication overuse headache (MOH): A randomized, single-blinded, placebo controlled study. Neurology. 2014, 82 (10 Suppl): 1-261. Cevoli S, Giannini G, Favoni V, Sancisi E, Nicodemo M, Zanignini S, Grimaldi D, Pierangeli G, Cortelli P: Treatment of withdrawal headache in patients with medication overuse headache (MOH): A randomized, single-blinded, placebo controlled study. Neurology. 2014, 82 (10 Suppl): 1-261.
Metadaten
Titel
O038. I.V. methylprednisolone plus diazepam in medication-overuse headache
verfasst von
Matteo Paolucci
Riccardo Altavilla
Giulia Gambale
Claudia Altamura
Fabrizio Vernieri
Publikationsdatum
01.12.2015
Verlag
Springer Milan
Erschienen in
The Journal of Headache and Pain / Ausgabe Sonderheft 1/2015
Print ISSN: 1129-2369
Elektronische ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-16-S1-A103

Weitere Artikel der Sonderheft 1/2015

The Journal of Headache and Pain 1/2015 Zur Ausgabe

Invited speaker presentation

Vestibular migraine

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.